Back

NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study

28 August 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Atrial fibrillation - Anticoagulation Cognitive Function and Autonomy in Patients with Atrial Fibrillation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Mette Soegaard

Aalborg University Hospital, Aalborg (Denmark)

6 More presentations in this session

Presentation thumbnail
Resuming anticoagulation in patients with atrial fibrillation experiencing hemorrhage stroke or nontraumatic intracranial hemorrhage
Assistant Professor V. Wu (Tao-Yuan, TW)
Abstract Slides
Presentation thumbnail
Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial
Doctor T. Nafee (Boston, US)
Abstract Slides
Presentation thumbnail
Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program
Doctor L. Riou Franca (Ingelheim, DE)
Abstract
Presentation thumbnail
Thrombosis of left atrial appendage closure devices - What is the clinical impact?
Doctor V. Lekesova (Prague, CZ)
Abstract Slides
Presentation thumbnail
Effect of anticoagulation on mortality by CHADSVASC score in patients with atrial fibrillation: comparison to patients without atrial fibrillation
Doctor S. Harb (Cleveland, US)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation - Anticoagulation

The Event

Event poster

ESC Congress 2018

28 August 2018 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources